New Analogues of the Nicotinamide Phosphoribosyltransferase Inhibitor FK866 as Potential Anti-Pancreatic Cancer Agents.
Irene ConfortiAndrea BenziIrene CaffaSantina BruzzoneAlessio NencioniAlberto MarraPublished in: Medicinal chemistry (Shariqah (United Arab Emirates)) (2024)
The positive results observed for some newly synthesized molecules, particularly those carrying a thiophene unit as a tail group, indicate that they could act as in vivo anti-pancreatic cancer agents.